Ann E. Woolfrey - Concepedia

Author

Ann E. Woolfrey

Also Known As

A E Woolfrey, A Woolfrey, A. E. Woolfrey, A. Woolfrey, A.E. Woolfrey, ANN WOOLFREY, Ann E Woolfrey, Ann E. Woolfrey, Ann Woolfrey, Lazarus, Hillard M.

209

Publications

11.7K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington Medical College of Wisconsin Oregon Health & Science University National Marrow Donor Program

About

Ann E. Woolfrey is an author at Fred Hutch Cancer Center specializing in medicine, hematology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	1.5K
2	Health Sciences	9	9	323
3	Public Health	4	4	221
4	Allergy	2	2	51
5	Biomedical Engineering	1	1	22

Ann E. Woolfrey

116

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood Claudio G. Brunstein, Jonathan A. Gutman, Daniel J. Weisdorf, Blood	2010	485
Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient Effie W. Petersdorf, Theodore A. Gooley, Claudio Anasetti, Blood	1998	475
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases Dietger Niederwieser, Michael B. Maris, Judith A. Shizuru, Blood	2003	455
Cord-Blood Transplantation in Patients with Minimal Residual Disease Filippo Milano, Ted Gooley, Brent L. Wood, New England Journal of Medicine	2016	429
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy Craig Kollman, Stephen R. Spellman, Mei-Jie Zhang, Blood	2015	341
Major-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation Effie W. Petersdorf, John A. Hansen, Paul J. Martin, New England Journal of Medicine	2001	336
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies Michael B. Maris, Dietger Niederwieser, Brenda M. Sandmaier, Blood	2003	335
Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning Frédéric Baron, Michael B. Maris, Brenda M. Sandmaier, Journal of Clinical Oncology	2005	333
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation Joseph Pidala, Stephanie J. Lee, Kwang Woo Ahn, Blood	2014	274
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia Robert Iannone, James F. Casella, Ephraim J. Fuchs, Biology of Blood and Marrow Transplantation	2003	271

Page 1